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Enhanced production of taxadiene 
in Saccharomyces cerevisiae
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Nestor Jonguitud‑Borrego1,2, Albert I. Lerma‑Escalera5, Jose R. Morones‑Ramirez5, Jay D. Keasling3,4,6,7,8 
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Abstract 
Background: Cost‑effective production of the highly effective anti‑cancer drug, paclitaxel  (Taxol®), remains limited 
despite growing global demands. Low yields of the critical taxadiene precursor remains a key bottleneck in microbial 
production. In this study, the key challenge of poor taxadiene synthase (TASY) solubility in S. cerevisiae was revealed, 
and the strains were strategically engineered to relieve this bottleneck.
Results: Multi‑copy chromosomal integration of TASY harbouring a selection of fusion solubility tags improved taxa‑
diene titres 22‑fold, up to 57 ± 3 mg/L at 30 °C at microscale, compared to expressing a single episomal copy of TASY. 
The scalability of the process was highlighted through achieving similar titres during scale up to 25 mL and 250 mL 
in shake flask and bioreactor cultivations, respectively at 20 and 30 °C. Maximum taxadiene titres of 129 ± 15 mg/L 
and 127 mg/L were achieved through shake flask and bioreactor cultivations, respectively, of the optimal strain at a 
reduced temperature of 20 °C.
Conclusions: The results of this study highlight the benefit of employing a combination of molecular biology and 
bioprocess tools during synthetic pathway development, with which TASY activity was successfully improved by 6.5‑
fold compared to the highest literature titre in S. cerevisiae cell factories.
Keywords: Taxadiene synthase, Saccharomyces cerevisiae, Paclitaxel, Taxol™, Yeast metabolic engineering, 
Minibioreactor
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Background
The highly complex diterpenoid drug Paclitaxel (Taxol™) 
first gained FDA approval in 1992 for the treatment of 
ovarian cancer and has since proven efficacious against 
a wide range of additional diseases [1]. Direct extrac-
tion from its natural source, the bark of Pacific yew 
(Taxus brevifolia), is both destructive and extremely 
low-yielding. As a result, paclitaxel is currently pro-
duced predominantly by semi-synthesis, involving the 
chemical modification of late precursors extracted from 
plant cell culture. However, as such methods are high 
in cost and have limited scalability, the development 
of a more sustainable source is critical to meet growing 
global demands [2]. One potential solution involves the 
heterologous expression of the biosynthetic pathway in 
microbial cell factories. The first committed step in the 
paclitaxel biosynthetic pathway is the cyclisation of the 
diterpenoid intermediate, geranylgeranyl diphosphate 
(GGPP) by taxadiene synthase (TASY), yielding taxa-
4(5),11(12)-diene (taxadiene) as shown in Fig. 1.
TASY is comprised of three alpha-helical domains; 
the active site is located within the C-terminal catalytic 
domain, where GGPP binds and is activated via a cluster 
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found to be relatively low compared to other terpene syn-
thases, with a 70-fold lower turnover rate than that of a 
plant abietadiene synthase with high sequence homol-
ogy [4]. In addition, the volume of the TASY active site is 
larger than that of taxadiene, contributing to previously 
observed enzyme promiscuity [5].
The reconstitution of this enzymatic step has been suc-
cessfully achieved in both E. coli [6, 7] and S. cerevisiae 
[8, 9] (Table 1). Through the adoption of a novel multi-
variate modular approach, Ajikumar et  al. [7] improved 
heterologous taxadiene titres to 300 and 1020  mg/L in 
E. coli shake-flask and fed-batch bioreactor cultivations, 
respectively. However, when the authors expressed the 
subsequent enzyme, taxadien-5α-hydroxylase, which is 
a membrane-bound cytochrome P450, a tenfold reduc-
tion in total taxane titre was observed. Membrane-bound 
cytochrome P450s like taxadien-5α-hydroxylase are esti-
mated to comprise around half of the 19 enzymatic steps 
in the paclitaxel biosynthetic pathway [10]. As the over-
expression of such membrane-bound enzymes is greatly 
Fig. 1 Engineered taxadiene biosynthetic pathway in S. cerevisiae. Genes highlighted in red represent native genes which have been overexpressed 
through the integration of one additional copy. Genes highlighted in blue are exogenous genes which were heterologously expressed. 
Hydroxymethylglutaryl‑CoA synthase (mvaS) and Acetyl‑CoA acetyltransferase (mvaE) from Enterococcus faecalis. Geranylgeranyl diphosphate 
synthase (crtE) from Xanthophyllomyces dendrorhous and Taxadiene synthase (TASY) from Taxus cuspidata 
Table 1 Summary of  previous taxadiene biosynthesis yields and  conditions using E. coli and  S. cerevisiae  as  microbial 
hosts
Host Taxadiene concentration Condition Reference
E. coli  ~ 300 mg/L 2 mL rich media, 22° C, IPTG induction, 5 days [7]
E. coli 1.02 ± 0.08 g/L 1 L fed‑batch cultivation, 22 °C, IPTG induction [7]
E. coli 94% of total product IPTG‑induced taxadiene synthase purification from E. coli (temperature shift from 
37 to 20 °C). A cell‑free assay was conducted afterwards.
[14]
E. coli 1.3 mg/L 1 L Luria–Bertani medium culture, IPTG‑induced taxadiene synthase expression 
(temperature shift from 37 °C to room temperature)
[15]
S. cerevisiae 8.7 ± 0.85 mg/L 100 mL buffered YPD medium in 500 mL baffled shake flask, two days, 28 °C [8]
S. cerevisiae 20 mg/L 5 mL YP‑galactose medium culture [9]
S. cerevisiae 0.7 mg/L 700 mL rich YP‑Galactose medium, 65 h [13]
S. cerevisiae 1.0 mg/L 700 mL Selective SG‑URA medium, 65 h [13]
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hindered in E. coli [11], the construction of the remain-
der of the pathway is likely to be very challenging in this 
bacterial host.
The eukaryotic host, S. cerevisiae, on the other hand, 
possesses the necessary biosynthetic machinery for the 
expression of such enzymes, including translocation 
through the endoplasmic reticulum and a native electron 
transfer machinery [12]. As in E. coli, early attempts to 
express TASY in S. cerevisiae were hindered by GGPP 
availability with a titre of just 122 µg/L in the wild type 
strain, which was insufficient for taxadiene synthesis [8]. 
DeJong et  al. [13] simultaneously incorporated GGPP 
synthase (GGPPS) and TASY from Taxus sp. into S. cer-
evisiae, leading to a taxadiene titre of 1  mg/L. Through 
the heterologous expression of a Sulfolobus acidocaldar-
ius geranylgeranyl diphosphate synthase (GDS), TASY, 
and a truncated HMG-CoA, taxadiene titres were later 
improved to 8.7 mg/L [8]. A subsequent study focussed 
on the careful selection of promoters, integration locus, 
and solubility tags, leading to the highest reported taxa-
diene titre of 20 mg/L in yeast [9].
Although taxadiene has been found to be the major 
product of TASY, with yields over 77%, around 5–13% 
of the total taxane product has been found to be the iso-
mer taxa-4(20),11(12)-diene (iso-taxadiene) [14–16]. 
Small quantities of a product tentatively identified as 
verticillene and an additional taxadiene isomer (taxa-
3(4),11(12)-diene) have also been detected in E. coli and 
Nicotiana benthamiana [16, 17].
The metabolic pathway of paclitaxel is highly complex 
and development of an alternative recombinant produc-
tion route remains in the preliminary stages. Despite this, 
substantial advancements in synthetic biology have been 
achieved recently [18]. Through the application of such 
tools, there is great potential to accelerate the develop-
ment of a microbial paclitaxel biosynthetic pathway. This 
study focussed on the optimisation of TASY enzyme per-
formance in S. cerevisiae to alleviate a key early pathway 
bottleneck. The effect of a number of factors including 
TASY truncation length, selected promoter and chro-
mosomal gene copy number on pathway expression were 
evaluated. Cultivation conditions such as culture tem-
perature and exogenous cofactor availability were also 
considered.
Results and discussion
Optimisation of taxadiene titre using episomal TASY 
expression
Four key parameters with the potential to affect final tax-
adiene titre were examined using a high-copy (2-micron) 
plasmid in the mGty116 S. cerevisiae strain. Such 
parameters included the selected promoter, cultivation 
temperature, cofactor  (Mg2+) concentration, and TASY 
sequence truncation. The results are summarised in 
Fig. 2.
In this study, the performance of four constitutive pro-
moters of increasing strength, pREV1, pSAC6, pRPL18B 
and pTDH3 [19] were compared to that of the strong 
inducible GAL1 promoter in S. cerevisiae, grown in 
SDGD-Leu media (Fig.  2a). Performance of the high-
est strength constitutive TDH3 and inducible GAL1 
promoters was highly similar with titres of 4.1 ± 0.3 
and 4.0 ± 0.3  mg/L, respectively. Decreasing promoter 
strength did not improve taxadiene titres, which were 1.6, 
2.9 and 8.2-fold lower for the weaker, RPL118B, SAC6 
and REV1 promoters, respectively. As changing the pro-
moter from the inducible GAL1 promoter resulted in no 
further improvement in taxadiene titre (Fig. 2a), pGAL1 
was selected for subsequent studies.
The growth temperature was found to have an impor-
tant effect on taxadiene titre as shown in Fig. 2b. Reduc-
ing the cultivation temperature from 30  °C to 20  °C 
resulted in a 3.0-fold increase in final taxadiene titre to 
8 ± 0.l  mg/L. However, at the lower temperature bio-
mass accumulation was also reduced, with a final  OD600 
of 2.90, compared to 4.5 at 30  °C. The temperature of 
20 °C selected in this study was based on the findings of 
a recent study by Abdallah et al. [21], showing that TASY 
expression in B. subtilis was greatly improved at 20  °C, 
as opposed to higher temperatures. This was in agree-
ment with previous results where heterologous expres-
sion of TASY in E. coli [20] and Bacillus subtilis [21] has 
also been found to be sensitive to culture temperature. 
Productivity analysis over a broad temperature range 
(12–37 °C) revealed a temperature optimum of 22 °C for 
both species [20]. In addition, the highest reported titre 
of 1020 mg/L was achieved in E. coli cultures at a tem-
perature of 22 °C [7].
TASY relies on the metal ion co-factor,  Mg2+, for acti-
vation and substrate orientation within the active site 
[22]. In a recent study by Tashiro et al. [23],  MgCl2 sup-
plementation was found to improve activity of an alter-
native diterpene synthase, pinene synthase, up to 20 mM 
in E. coli. As the concentration of  Mg2+ in the SDGD-
Leu medium was around 0.8  mM, it was hypothesised 
to be rate limiting. However, supplementation of the 
cultivation medium with additional  MgCl2 did not sig-
nificantly improve taxadiene titres at 20 or 30  °C in this 
study (Fig.  2c). Consequently, additional  MgCl2 supple-
mentation was not deemed necessary for subsequent 
experiments.
The native TASY gene encodes 862 amino acids, 
including a putative N-terminal sequence of ~ 137 resi-
dues which is cleaved upon maturation in plastids [3]. 
Removal of this sequence was found to reduce inclusion 
Page 4 of 12Nowrouzi et al. Microb Cell Fact          (2020) 19:200 
body formation, while increasing active and soluble pro-
tein production in E. coli [3, 14] In order to determine the 
optimal protein length for TASY expression in S. cerevi-
siae with the aim to achieve an improved TASY solubil-
ity, a range of truncation lengths were tested (Fig.  2d). 
Increasing truncation length up to 60 residues improved 
taxadiene production from 6.0 ± 0.5 to 13.0 ± 0.8  mg/L 
as shown in Fig. 2d. In variants harbouring longer trun-
cations, no further improvement in taxadiene titre was 
observed. The TASY variant with a 60-residue trunca-
tion was therefore selected for subsequent experiments. 
These results were in agreement with previous works 
where truncations of 60 or 79 residues yielded active pro-
tein and reduced inclusion body formation, whilst trun-
cations of 93 or more residues produced inactive protein 
in E. coli [14].
Chromosomal integration of TASY
Comparing episomal and chromosomal expression
Plasmid-based systems rely on the use of expensive 
selective media, limiting their industrial relevance. In a 
previous study, a single copy of the TASY gene was chro-
mosomally integrated into the mGty116 strain. Cultiva-
tion of the resulting LRS2 (pTDH3-TASY-tADH1) strain 
at 30  °C resulted in a taxadiene titre of 2.6 ± 0.4  mg/L 
[9]. Interestingly, this titre was comparable to the 
2.7 ± 0.2  mg/L achieved using the high-copy 2-micron 
plasmid system in this study (Fig. 2b). The effect of sta-
ble chromosomal TASY integration in yeast was there-
fore investigated in the mGty116 strain of this study. In 
order to visualise functional TASY expression, TASY 
was tagged with a C-terminus GFP reporter gene (strain 
LRS3). Cultivation of this strain yielded 12 ± 1  mg/L of 
taxadiene at 30 °C, 4.7-fold higher than that of the LRS2 
strain. This was also comparable to the optimal plasmid-
based titre of 13 ± 1 mg/L achieved at the lower tempera-
ture of 20 °C (Fig. 2d). This suggested that chromosomal 
integration improved taxadiene titre in comparison to 
episomal expression.
Effect of gene copy number and solubility tags
Fusion tags are often used to improve protein expres-
sion and solubility [24]. A recent study using a range 
of tags, revealed that maltose binding protein (MBP), 
had the greatest positive impact on TASY solubil-
ity and activity in S. cerevisiae [9]. Prenyltransferase-
terpene synthase fusion proteins have also been found 
to greatly improve terpene production [25, 26]. The 








































































































































Fig. 2 Optimisation of taxadiene titres using episomal TASY expression. a Effect of promoter on taxadiene concentration produced by cells 
incubated at 30 °C. b Effect of cultivation temperature on taxadiene titre. c Effect of cofactor  (Mg2+) availability at 20 and 30 °C. d Effect of gene 
truncation length for taxadiene production at 20 °C. Values shown are mean ± standard deviation for 96‑h triplicate cultivations
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prenyltransferase, farnesyl diphosphate synthase, 
encoded by ERG20 catalyses the formation of the gera-
nyl diphosphate (GPP) and farnesyl diphosphate (FPP) 
metabolites, two key enzymatic steps in the mevalonate 
pathway (Fig.  1). ERG20 has been reported to signifi-
cantly improve isoprenoid concentration when used 
as a fusion protein with terpene synthases, potentially 
promoting enzyme solubility as well as increasing the 
pool of the isoprenoid precursor farnesyl diphos-
phate [25, 27]. Deng et al. [26] showed that the fusion 
of a mutant variant of ERG20 to (S)-linalool synthase 
improved the productivity by around 70% compared to 
independent integration of the two genes in S. cerevi-
siae. Hence, a cassette containing an N-terminal yeast 
codon-optimised MBP tagged TASY-ERG20* (F96C; 
[25]) fusion gene was developed with the dual aim of 
increasing precursor availability and improving TASY 
solubility. This cassette was chromosomally integrated 
into locus ARS1014a of LRS3 to yield strain LRS4. The 
integration of a second copy of this dual-tagged TASY 
in locus ARS1622b resulted in strain LRS5 (1 × TASY-
GFP, 2 × MBP-TASY-ERG20*, Fig.  3). These two loci 
were previously reported to show high expression rate 
as tested with a GFP reporter [9].
Cultivation of the newly constructed LRS4 strain 
expressing two copies of TASY resulted in an 
over three-fold improvement in taxadiene titre to 
40 ± 3  mg/L at microscale. Through cultivation of the 
subsequent LRS5 strain, taxadiene titres were further 
enhanced to 57 ± 3  mg/L at 30  °C, the highest titre in 
yeast reported to date at microscale level (Fig. 4).
Through effective copy number optimisation and the 
use of MBP and GFP tags along with an ERG20 fusion, 
taxadiene production was enhanced up to 22-fold in S. 
cerevisiae (Fig. 4). This was likely the result of improved 
protein expression and solubility, as well as increased 
FPP availability for the synthetic pathway [27]. Never-
theless, fluorescent visualisation still showed substan-
tial spotted subcellular localization (Additional file  1: 
Fig. 3 Chromosomally integrated TASY genetic constructs. From top 
to bottom are TASY cassettes integrated at loci: ARS1114a, ARS1014a, 




































Fig. 4 Summary of taxadiene titers microscale optimisation study. LRS1 indicates titers resulting from episomal TASY expression using the high 
copy 2‑micron plasmid (LRS1) at 30 and 20 °C, respectively. The other titers are from strains with chromosomally integrated TASY variants: LRS2 
(TDH3p‑TASY‑ADH1t), LRS3 (TASY‑GFP), LRS4 (TASY‑GFP; MBP‑TASY‑ERG20*) and LRS5 (TASY‑GFP; MBP‑TASY‑ERG20*; MBP‑TASY‑ERG20*), respectively, 
grown at 30 °C
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Figure S1), which was consistent with a previous study 
highlighting the poor solubility of TASY [9].
Taxadiene production scale‑up
Minor product characterisation at increased scale 
under different temperatures
In order to investigate process scalability, the optimised 
LRS5 strain was subsequently cultivated in 250-mL shake 
flasks (25  ml working volume). The effect of tempera-
ture on chromosomal TASY expression by the optimised 
strain was also assessed through cultivation at both 20 °C 
and 30 °C. The results of this experiment are summarised 
in Fig. 5.
The final taxadiene titre at 20  °C was 129 ± 15  mg/L, 
representing an almost 6.5-fold improvement over 
the highest reported titre [8]. The final titre at 30  °C 
was 56.9 ± 2.7  mg/L, which was comparable to the 
57 ± 3  mg/L obtained in the smaller scale cultivations 
(Fig. 4). This represented a 2.3-fold lower taxadiene titre 
at 30  °C compared to 20  °C, indicating that despite the 
addition of solubility tags, further optimisation is likely 
to be necessary at higher growth temperatures. Inter-
estingly, biomass accumulation was very similar for the 
strain in nutrient rich YPG medium, with final  OD600 
values of 29 ± 1 and 31 ± 1 at 20 and 30  °C, respectively 
(Fig.  5b). In selective, dropout medium (SDGD-Leu, 
Fig.  2b), however, a 36% lower final biomass yield was 
achieved at 20 °C. The more prominent effect of cultiva-
tion temperature on growth rate observed in the selective 
medium was likely the result of an increased metabolic 
burden associated with plasmid expression coupled with 
the reduced nutrient availability in SDGD-Leu medium 
compared to YPG.
Although taxadiene was the major product under all 
conditions studied, additional side products were also 
generated, due to TASY promiscuity [28]. At this scale, 
further characterisation of such side products was per-
formed through a detailed analysis of gas chromatog-
raphy (Fig.  6) and mass spectrometry data (Additional 
file 1: Figure S2).
In addition to taxadiene, which was eluted at 8.10 min 
(Additional file  1: Figure S2-D), a further five diterpene 
products were detected as shown in Fig.  6. The mass 
spectra of the peaks at 7.43 and 7.88  min (Additional 
file  1: Figures  S2-A, C) showed a high degree of simi-
larity to compounds previously identified as verticil-
lene and the taxadiene isomer, taxa-4(20),11(12)-diene 
(iso-taxadiene), respectively [14, 16]. Verticillene is a 
bridged bicycle product formed as part of a series of 
carbocation-mediated cyclisations involved in taxadi-
ene synthesis from acyclic GGPP [29]. An additional 
two diterpene compounds, Diterpene 1 and Diterpene 2 
(Additional file 1: Figures S2-B and S2-E) were observed 
at 7.78 and 8.16 min, respectively. The mass spectrum of 
diterpene 1 closely resembled cembrene-type diterpene 
(cembrene A) produced by neocembrene synthase in 
S. cerevisiae [30]. The cyclisation of GGPP to taxadiene 
involves production of a cembrenyl intermediate [31]. 
The relatively high degree of similarity suggests the com-















































Fig. 5 Effect of temperature on LRS5 performance in shake flasks. LRS5 was cultivated in 250 mL shake flasks in YPG media at 20 or 30 °C. Taxane 
accumulation (a) and yeast growth (b) were evaluated after 72 h of cultivation. Error bars represent ± standard deviation for triplicate cultivations
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product of this cyclisation step. However, further char-
acterisation is needed to confirm this. The mass spec-
trum and elution order of diterpene 2 was very similar 
to that of a novel diterpene product of TASY expression 
in Nicotiana benthamiana [17]. Production of gera-
nylgeraniol (GGOH) (8.83 min; Additional file 1: Figure 
S2-F) was also confirmed using a pure analytical stand-
ard. Although GGOH is formed naturally by S. cerevisiae 
through the degradation of GGPP by endogenous phos-
phatases, titres are typically too low to detect [32]. Its 
overproduction here indicates that early work to over-
express the mevalonate pathway was successful, how-
ever, taxadiene titres could be improved further through 
pathway optimisation. Huang et  al. showed that trun-
cated TASY has dual activity, which besides taxadiene 
isomers, can also synthesize sesquiterpenes using FPP as 
the substrate instead of GGPP [33]. Here, in addition to 
the diterpene products, a number of additional potential 
terpenoid side-products were detected between 4.36 and 
6.38 min (Additional file 1: Figures S3 and S4). Although 
TASY enzyme has been evolved to reduce its promiscu-
ity through direct intramolecular proton transfer in the 
last step to taxadiene formation, it is prone to side prod-
uct generation due to carbocations involved in GGPP 
to taxadiene cyclisation [28]. Despite this, to minimise 
the production of these side products, increasing the 
metabolic flux towards GGPP formation seems neces-
sary. Although paclitaxel biosynthesis can also proceed 
through iso-taxadiene, taxadiene is the main precur-
sor in paclitaxel biosynthesis pathway [16]. However, to 
increase the selectivity of TASY towards taxadiene for-
mation, enzyme engineering approaches are essential. 
This can be achieved through rational and evolutionary 
approaches due to availability of its protein structure [3, 
5]. For instance, Edgar et al. improved the yield and selec-
tivity for iso-taxadiene by 2.4-fold and reduced taxadiene 
production [34].
Scale‑up using a mini‑bioreactor system
A tenfold scale-up of the LRS5 cultivation was used to 
assess performance under industrial conditions for taxa-
diene production. A 500-mL MiniBio bioreactor (App-
likon, UK) was employed for this study. This system 
possesses the online monitoring and control capabili-
ties of larger-scale bioreactors, allowing industrial scale 
cultivation conditions to be effectively mimicked whilst 
conserving valuable resources. The results of the bioreac-
tor-scale runs are summarised in Fig. 7.
Following 72  h of cultivation, the  OD600 values of the 
20 and 30 °C cultivations were 10.6 and 14.6 respectively 
as shown in Fig.  7a and c. This was significantly lower 
than the 29 ± 1 and 31 ± 1 obtained at shake flask scale 
(Fig.  5b). Taxadiene titres were also lower in the biore-
actor studies at 27 and 35  mg/L compared to 129 and 
57 mg/L for the equivalent 20 and 30 °C shake flask cul-
tures. Despite this, following a further 30 h of cultivation, 
the stationary phase of growth was reached, and a maxi-
mum taxadiene titre of 53 mg/L was attained in the 30 °C 
reactor. This was highly comparable to those obtained 
in the 72-h microscale (Fig.  4) and shake flask (Fig.  5a) 
Fig. 6 LRS5 gas chromatogram. Results show products produced by LRS5 during the 30 °C shake flask cultivation
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cultivations. A higher taxadiene titre of 109  mg/L was 
achieved in the 20  °C bioreactor, however, a bioreactor 
run time of 195  h was required. Interestingly, produc-
tion of the endogenous GGOH side product was dra-
matically reduced at the increased scale with maximum 
titres of 4 and 5 mg/L (Fig. 7b, d) compared to 19 ± 3 and 
35 ± 1 mg/L for the equivalent 20 and 30  °C shake flask 
studies (Fig. 5a).
Unlike prokaryotes, eukaryotic yeast cells have evolved 
to store hydrophobic compounds within specialised orga-
nelles (liquid droplets) [35]. As a result, it was hypoth-
esised that additional taxadiene may be present within 
the yeast cells. An investigation into intracellular taxane 
production was therefore performed on samples taken 
from the higher-yielding 20  °C bioreactor cultivation as 
summarised in Fig. 8.
In the first 168  h of the cultivation, both extracellu-
lar and intracellular taxadiene accumulation increased 
(Fig. 8). In the subsequent 48 h, a sharp decline in intra-
cellular taxadiene from 31 to 11 mg/L was observed. This 
was coupled with an increase in extracellular taxadiene 
from 95 to 109 mg/L while the total taxadiene concentra-
tion remained similar between 119 and 127 mg/L (Fig. 8). 
This suggested that the increase in extracellular taxadiene 
concentration observed in the last 48 h was likely largely 
due to taxadiene secretion rather than additional taxadi-
ene biosynthesis.
The temperature can impact gene expression and pro-
tein folding [20]. Also, it has been shown that at a lower 



















































































































































































































Fig. 7 Bioreactor studies results and respective taxane concentration kinetics at 20 °C (a, b) and at 30 °C (c, d).  LRS5 was cultivated in an Applikon 
MiniBio 500 bioreactor in yeast extract (1%), peptone (2%), galactose (2%). The pH and dissolved oxygen were monitored online and controlled to 
set points of 6 and 30%, respectively online




























Fig. 8 Kinetics of intracellular and total taxadiene titres in 
high‑yielding 20 °C bioreactor cultivation
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temperature, mevalonate pathway genes are overex-
pressed in S. cerevisiae [36], providing more precursors 
to TASY. It is also likely that lower temperature has influ-
enced TASY solubility, as was shown in previous stud-
ies for terpene synthase expression in E. coli [37, 38]. 
Moreover, as there was a concurrent decrease in the titre 
of GGPP side product (GGOH) at 20  °C, at both shake 
flask and bioreactor cultivations (Figs. 5a and 7b), it can 
be postulated that TASY activity was improved at lower 
temperature, resulting in more rapid GGPP consump-
tion and reducing its accumulation to become degraded 
to GGOH by endogenous phosphatases [32]. In line 
with these facts, a lower cultivation temperature of 20 °C 
was found to improve TASY performance with higher 
taxadiene titres being obtained under all the conditions 
investigated in this study. However, the kinetic analysis 
revealed a strong positive correlation between biomass 
and product accumulation at both 20 and 30  °C (Pear-
son’s R = 0.916 and 0.974, respectively). As the growth 
rate of LRS5 decreased with temperature, longer cul-
tivation time was required at 20  °C. This was exacer-
bated at larger scale, where cultivation time was tripled 
(Fig. 7a). Although careful optimisation yielded substan-
tial improvements in TASY productivity in this study, 
the discrepancies between the optimal temperature for 
the enzyme and host growth remain a challenge. The 
optimisation of copy number and protein tag combina-
tion improved taxadiene titres dramatically in this study. 
However, the higher titres obtained at reduced tempera-
ture indicate further optimisation is needed at the opti-
mal growth temperature of 30 °C.
Conclusions
This study reports the successful optimisation of taxadi-
ene biosynthesis in a Saccharomyces cerevisiae microbial 
chassis. Low expression and poor solubility of taxadiene 
synthase (TASY) were identified as critical bottlenecks. 
This was alleviated through multi-copy chromosomal 
integration of TASY with a combination of fusion protein 
tags, improving taxadiene titres 22-fold to 57 ± 3  mg/L 
at 30  °C. TASY performance was found to be temper-
ature-dependant, with a maximum taxadiene titre of 
129 ± 15  mg/L at 20  °C. Similar titres were achieved at 
larger scale as well, highlighting the scalability of the bio-
process, and representing a 6.5-fold improvement on the 
highest literature titre.
This work highlights the benefit of multifactorial 
approach to biosynthetic pathway optimisation, where a 
combination of molecular biology tools and bioprocess-
ing approaches were employed. Although the current 
study presents significant progress in taxadiene biosyn-
thesis, several tasks remain to improve the expression of 
taxadiene synthase at 30 °C to allow for further paclitaxel 
biosynthetic pathway development in S. cerevisiae.
Methods
Yeast strains and media
The parent S. cerevisiae strain used for episomal expres-
sion and integration studies was GTy116 (MATa,  leu2-
3, 112::HIS3MX6-GAL1p-ERG19/GAL10p-ERG8; 




CrtE(opt)/GAL10p-CrtE) described previously by [9], 
originating from CEN.PK2-1C (EUROSCARF collection). 
The URA3 marker of this strain was further restored to 
give mGty116. All chemicals and reagents were sourced 
from Sigma-Aldrich at the highest available purity unless 
otherwise stated. Episomal expression systems made use 
of synthetic defined medium minus uracil (CSM-Ura and 
CSM-Leu, Sunrise Science Products) depending on the 
selection marker used. These were supplemented with 2% 
(w/v) glucose (SDD-Leu), 2% (w/v) galactose (SDG-Leu) 
or a 1.8% (w/v) galactose, 0.2% (w/v) glucose mixture 
(SDGD-Leu). For cultivation of strains harbouring chro-
mosomally integrated genes, a medium containing yeast 
extract (1%(w/v)) and peptone (2%(w/v)), supplemented 
with 2% (w/v) glucose (YPD), galactose (YPG) or 1.8% 
(w/v) galactose and 0.2% (w/v) glucose mixture (YPGD) 
were used.
Yeast transformation and strain construction
Episomal expression was achieved through transform-
ing S. cerevisiae with high copy 2-micron plasmids har-
bouring TASY and a LEU2 selection marker (Additional 
file 1: Table S1). The standard LiAc/SS carrier DNA/PEG 
method was used for all transformations [39]. Chromo-
somal integration was performed using a cloning free, 
Cas9-mediated homologous recombination method [9]. 
High copy number, Cas9-sgRNA 2-micron plasmids har-
bouring a URA3 selection marker derived from pRS426 
were used. The gene cassettes were designed using an 
online tool, CASdesigner. Chromosomal integration at 
the target site was confirmed by colony PCR and Sanger 
sequencing (Genewiz Inc., USA; Edinburgh Genomics, 
UK). Plasmid curing was subsequently performed on suc-
cessful colonies through sequential culture on YPD agar 
medium until no growth was observed on concurrent 
SDD-Leu agar plates.
The strains used in this study are summarised in Table 2 
and plasmid, primer and tag sequences are tabulated in 
Additional file 1: Tables S1–3. All DNA sequences were 
synthesised by IDT (Integrated DNA Technologies, Inc.). 
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A TASY sequence from Taxus cuspidata was codon opti-
mised for expression in S. cerevisiae. DNA amplification 
was performed using Phusion Flash High-Fidelity PCR 
Master Mix (Thermo Fisher Scientific). Promoter and 
terminator sequences native to the yeast genome were 
selected [19].
Optimisation of taxadiene producton at microscale
Preliminary microscale episomal expression studies 
involved 5 ml cultures of the mGTy116 strain harbouring 
selected high-copy 2-micron plasmids as shown in Addi-
tional file  1: Table  S1. Inocula were prepared through 
transferring a single yeast colony to 5  ml of SDD-Leu 
medium, followed by incubation overnight at 30  °C. 
Aliquots of the inoculum were diluted with SDGD-Leu 
medium to give an initial  OD600 = 0.5. The yeast cultures 
were incubated at 20 or 30 °C and 200 rpm for 96 h. To 
minimise air-stripping of the volatile terpene products, a 
biphasic liquid–liquid system was used through the addi-
tion of a 10% (v/v) dodecane overlay after 24 h of cultiva-
tion. At the end of the cultivation, the resulting cultures 
were centrifuged, and the organic dodecane layer was 
extracted for GC–MS analysis. Microscale culture of the 
strains harbouring chromosomally integrated genes was 
done in a similar way as for episomal expression, except 
that YPD and YPGD media were used for the inoculum 
and production cultures, respectively.
Shake flask cultivations
Single LRS5 colonies were transferred from YPD agar to 
5 mL YPD medium and incubated at 30 °C and 250 rpm 
overnight. Aliquots of these cultures were then used 
to inoculate 20  mL YPG in 250  mL shake flasks to an 
 OD600 = 1. A 20% (v/v) dodecane overlay was used giv-
ing a total working volume of 25 mL. The resulting cul-
tures were incubated at 20 or 30 °C and 250 rpm for 72 h. 
At the end of the cultivation, the dodecane overlay was 
extracted for GC–MS analysis. The final biomass was 
measured at an optical density of 600 nm.
Batch culture in the bioreactor
Cultivations were conducted in MiniBio 500 mL bioreac-
tors (Applikon  Biotechnology,  The  Netherlands) with a 
working volume of 250  mL. Pre-inocula  were prepared 
by incubating cells in 5 mL of YPD for eight hours. The 
resulting cultures  were used  to inoculate secondary 
10-mL inocula to an  OD600 = 1, which were subsequently 
incubated at 30 °C and 200 rpm overnight. An aliquot of 
an inoculum culture was then diluted with YPG to give 
a 200  mL culture with an initial  OD600 = 1. To prevent 
excess  foam production, polypropylene glycol  P2000 
(Fisher Scientific, UK) was added to a concentration 
of 0.01% (v/v) and a Rushton turbine was placed at the 
medium-air interface. A 20% (v/v) dodecane (Fisher Sci-
entific, UK) overlay was also added to minimise product 
loss due to air stripping. During cultivation, the tempera-
ture, dissolved oxygen and pH  were monitored  online. 
Biomass  was measured  through manual sampling twice 
daily. The adaptive my-Control system (Applikon  Bio-
technology,  The  Netherlands) was used to control pro-
cess parameters. Setpoints of 30% of the saturation and 
30 °C were applied for dissolved oxygen and temperature, 
respectively. The culture pH was controlled to a setpoint 
of six through automatic addition of 1 M NaOH. Samples 
were taken twice daily for analysis of taxane and biomass 
concentration.
Diterpene analysis and quantification
The dodecane overlay was analyzed by GC–MS using 
Trace 1300 GC (ThermoFisher Scientific), equipped 
with TG-SQC column (15 m × 0.25 mm × 0.25 μm). The 
mass spectra in the range of 50–650  m/z was recorded 
on a Thermo Scientific ISQ Series single quadrupole 
mass spectrometer using EI ionization mode and scan 
time of 0.204 s. The GC temperature programme began 
at 120 °C (3 min) and was then raised to 250 °C at a rate 
of 20  °C/min with 3 min hold time. Xcalibur™ software 
(ThermoFisher Scientific, USA) was employed for data 
processing. Pure taxadiene (kindly supplied by Baran 
Table 2 Yeast strains used in this study
Strain name Genotype Reference
GTy116 MATa, leu2-3, 112::HIS3MX6-GAL1p-ERG19/GAL10p-ERG8; ura3-52::URA3-GAL1p-MvaSA110G/GAL10p-
MvaE (codon optimised); his3Δ1::hphMX4-GAL1p-ERG12/GAL10p-IDI1; trp1-289::TRP1_GAL1p-
CrtE(X.den)/GAL10p-ERG20; YPRCdelta15::NatMX-GAL1p-CrtE(opt)/GAL10p-CrtE
[9]
LRS1 mGTy116 Yep_Gal1p-3Xflag-M60TASYBRE-CYC1 This study
LRS2 mGTy116 ARS1014a::TDH3p-TASY-ADH1t [9]
LRS3 mGTy116 ARS1014a::Gal1p-TASY-GFP This study
LRS4 LRS3 ARS1622:: Gal1p-MBP-TASY-ERG20* This study
LRS5 LRS4 ARS1114a::Gal1p-MBP-TASY-ERG20* This study
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Lab, The Scripps Research Institute) and geranylgeraniol 
(Sigma Aldrich, UK) were used as standards to identify 
and quantify taxadiene and GGOH, respectively. Addi-
tional taxane products were quantified relative to stand-
ard taxadiene concentrations.
Intracellular taxadiene quantification
Intracellular taxadiene accumulation was quantified 
in the 20  °C bioreactor samples. Cell lysis was achieved 
using a previously described protocol [40] with some 
modifications. In summary, 1  mL of the aqueous cul-
ture phase was centrifuged and the cell pellet was resus-
pended in a mixture containing 0.4  mL of yeast lysis 
reagent (2% (v/v) Triton X100,1% (w/v) SDS, 100  mM 
NaCl, 10 mM Tris–HCl (pH 8.0) and 1 mM EDTA (pH 
8.0)) and 0.4 mL of 1 M HCl for cell lysis. The resulting 
suspension was mixed thoroughly prior to the addition of 
a 1-mL dodecane overlay. The samples were subsequently 
incubated at 30 °C, 200 rpm for 16 h before separation of 
the organic phase for GC–MS analysis.
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